Survey Finds Patients Wary of Rx Switches--October 2008

Lauren Green, Associate Editor
Published Online: Thursday, October 16, 2008
Follow Pharmacy_Times:

A survey by the National Consumers League (NCL) has found that 70% of prescription drug users would be very concerned if a drug they were prescribed was switched to another medication designed to treat the same condition without the knowledge of their physician. Even with the doctor’s knowledge, 1 respondent in 5 is concerned about the practice.

“Consumers are justifiably concerned about the practice of therapeutic substitution, how it’s done, and who’s involved,” said NCL Executive Director Sally Greenberg. “For some conditions and treatments, it may make good financial or medical sense to swap out one prescription for another. But, as consumers reported in our survey, it’s essential for them to be part of the process, to know their doctor is aware and supportive of the switch, and to feel confident that their health and treatment—not financial incentives—are top priority.”

Among other findings, NCL reports that only 19% of survey respondents would consider switching to a different medication meant to treat the same disease if their insurance company sent a letter recommending the change; receiving such a letter would inspire 71% of them to have a conversation with their doctor about a less expensive drug, however.

The online survey of 1387 adults aged 18 and older who filled a prescription in the last year was conducted by Harris Interactive between August 25 and September 2; the sample included 352 patients currently taking a statin medication.

NCL has launched a public education campaign to help patients better understand the practice of therapeutic substitution. Fact sheets and other resources for patients, as well as complete survey results, are available at www.nclnet.org.

For other articles in this issue, see:

Kids’ OTC Cough, Cold Meds to Get New Labels

Rogue Pharmacy Crackdown Expected to Become Law

PDPs for Low-Income Beneficiaries Decreasing in ’09



Related Articles
While there is currently no standard treatment, vaccine, or cure for Ebola, there are still some experimental treatments in 3 drug class with more to come.
From a bad customer service experience, independent musician Dave Carroll learned valuable lessons that apply to independent community pharmacists.
Though the fall semester is underway, it’s not too late to change your studying habits.
Latest Issues
$auto_registration$